Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis: A new approach

Journal of Dermatology

Volumn 23, Issue 4, 1996, Pages 259-262

  Alpsoy, Erkan ^a   Yilmaz, Ertan ^a   Basaran, Erdal ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

intermittent; onychomycosis; terbinafine; treatment

Indexed keywords

ANTIFUNGAL AGENT; TERBINAFINE;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHYTE; DIARRHEA; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFICACY; DRUG STABILITY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER; TOE; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

EID: 0029935002     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1996.tb04009.x     Document Type: Article

References (13)

1. Petranyi G, Ryder NS, Stütz A: Allylamine derivates: New class of synthetic antifungal agents inhibiting fungal squalene epoxidase, Science, 224: 1239-1241, 1984.
2. Petranyi G, Meingassner JG, Mieth H: Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother, 31: 1365-1368, 1987.
3. Clayton YM: In vitro activity of terbinafine, Clin Exp Dermatol, 14: 101-103, 1989.
4. Ryder NS: Specific inhibition of fungal sterol biosynthesis by SF 86327, a new allylamine antimycotic agent, Antimicrob Agents Chemother, 27: 252-256, 1985.
5. Goodfield MJD, Rowell NR, Forster RA, et al: Treatment of dermatophyte infection of the finger- and toe-nails with terbinafine (SF86-327, Lamisi). An orally active fungucidal agent, BrJ Dermatol (suppl), 121: 753-757, 1989.
6. Zaias A: Management of onychomycosis with oral terbinafine, J Am Acad Dermatol, 23: 810-812, 1990.
7. Goodfield MJD: Short-duration therapy with terbinafine for dermatophyte onychomycosis: A multicentre study, Br J Dermatol, 126 (suppl): 33-35, 1992.
8. Van Der Schroeff JG, Cirkel PKS, Crijins MB, et al: A randomized treatment duration-finding study of terbinafine in onychomycosis, BrJ Dermatol, 126: 36-39, 1992.
9. Finlay AY, Lever L, Thomas R, et al: Nail matrix kinetics of systemic terbinafine in onychomycosis and normal nails, J Dermatol Treat, 1 (suppl): 51-53, 1990.
10. Finlay AY: Pharmacokinetics of terbinafine in the nail, Br J Dermatol, 126 (suppl): 28-32, 1992.
11. Faergemann J, Zehender H, Denouel J, et al: Levels of terbinafine in plasma, stratum corneum, dermisepidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks, Acta Derm Venereal, 73: 305-309, 1993.
12. Finlay AY: Pharmacokinetics of terbinafine, J Dermatol Treat, 3 (suppl 1): 15-17, 1992.
13. Shuster S, Munro CS: Single-dose treatment of fungal nail disease, Lancet, 339: 1066, 1992.